Protracted Mycobacterium kansasii carpal tunnel syndrome and tenosynovitis.
Lidar
Merav
M
Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Elkayam
Ori
O
Goodwin
David
D
Yaron
Michael
M
Caspi
Dan
D
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001249:Asthma / Q000150:complications / Q000188:drug therapy; D002349:Carpal Tunnel Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003646:Debridement; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D019909:Mycobacterium kansasii; D011241:Prednisone / Q000009:adverse effects; D012086:Reoperation; D013717:Tenosynovitis / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D011241:Prednisone